BRAIN Biotech AG (ETR:BNN)

BRAIN Biotech AG Balance Sheet

Financials in millions EUR. Fiscal year is October - September.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	-	6.19	27.17	5.35	8.44	24.55
Short-Term Investments	-	0.13	0.06	0.06	0.08	0.06
Cash & Short-Term Investments	-	6.32	27.23	5.41	8.53	24.6
Cash Growth	-	-76.81%	403.59%	-36.58%	-65.35%	29.50%
Accounts Receivable	-	8.46	7.8	9.44	8.04	6.72
Other Receivables	-	0.42	0.32	0.27	3.24	0.13
Receivables	-	9	8.24	9.83	11.35	6.95
Inventory	-	8.94	9.42	9.76	9.66	7.02
Prepaid Expenses	-	0.6	0.6	0.39	0.33	0.32
Other Current Assets	19.97	0.11	0.17	0.09	0.52	0.23
Total Current Assets	19.97	24.96	45.66	25.48	30.38	39.11
Property, Plant & Equipment	-	27.55	27.86	28.72	28.74	24.29
Long-Term Investments	-	1.28	0.97	1.46	1.94	0.55
Goodwill	-	6.63	6.81	6.67	6.61	4.73
Other Intangible Assets	-	5.87	7.38	8.55	10.16	8.81
Long-Term Deferred Charges	-	0.06	0.07	0.02	0.06	-
Other Long-Term Assets	39.42	0	-	-	0.01	0.1
Total Assets	59.39	66.34	88.74	70.94	77.99	77.74

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Accounts Payable	-	4.36	5.61	5.62	6.75	3.83
Accrued Expenses	-	2.8	5.91	3.6	2.67	2.28
Current Portion of Long-Term Debt	-	6.22	7.41	2.26	1.43	1.24
Current Portion of Leases	-	1.72	1.57	1.44	1.27	1.08
Current Income Taxes Payable	-	-	-	0.04	0.17	0.06
Current Unearned Revenue	-	1.13	0.62	2.93	1.99	1.57
Other Current Liabilities	14.87	1.38	3.89	1.59	7.1	1.27
Total Current Liabilities	14.87	17.6	25.01	17.48	21.39	11.34
Long-Term Debt	-	5.51	10.71	-	2.62	3.48
Long-Term Leases	-	7.29	6.62	6.74	5.41	5.58
Long-Term Unearned Revenue	-	0.38	1.12	0.52	0.77	1.11
Pension & Post-Retirement Benefits	-	0.7	0.93	0.93	1.15	2.27
Long-Term Deferred Tax Liabilities	-	3.35	3.88	3.77	3.29	2.79
Other Long-Term Liabilities	51.64	29.67	26.59	18.49	9.11	9.35
Total Liabilities	66.51	64.5	74.85	47.92	43.74	35.91

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Common Stock	-7.12	21.85	21.85	21.85	21.85	21.85
Additional Paid-In Capital	-	95.73	94.95	93.46	92.66	95.89
Retained Earnings	-	-116.04	-105.49	-94.16	-85.2	-79.51
Comprehensive Income & Other	-	0.3	1.31	0.63	0.33	0.56
Total Common Equity	-7.12	1.84	12.62	21.77	29.64	38.78
Minority Interest	-	-	1.27	1.24	4.61	3.04
Shareholders' Equity	-7.12	1.84	13.89	23.01	34.25	41.83
Total Liabilities & Equity	59.39	66.34	88.74	70.94	77.99	77.74

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Total Debt	-	20.73	26.3	10.44	10.74	11.38
Net Cash (Debt)	-	-14.42	0.93	-5.03	-2.21	13.22
Net Cash Growth	-	-	-	-	-	123.82%
Net Cash Per Share	-	-0.66	0.04	-0.23	-0.10	0.66
Filing Date Shares Outstanding	21.85	21.85	21.85	21.85	21.85	21.85
Total Common Shares Outstanding	21.85	21.85	21.85	21.85	21.85	21.85
Working Capital	5.1	7.36	20.65	8	9	27.78
Book Value Per Share	-0.33	0.08	0.58	1.00	1.36	1.78
Tangible Book Value	-7.12	-10.65	-1.57	6.56	12.87	25.25
Tangible Book Value Per Share	-0.33	-0.49	-0.07	0.30	0.59	1.16
Land	-	10.47	10.66	10.42	10.33	16.26
Machinery	-	21.7	22.19	21.55	22.68	20.59
Construction In Progress	-	1.02	0.19	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error